- Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings The Wall Street Journal
- Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar CNBC
- Lilly Ups Guidance on Weight Loss, Obesity Drugs’ Strength Bloomberg.com
- Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine statnews.com
- Eli Lilly Stock Rises on Earnings and Boost to Guidance Barron’s
Source link
![Apple reports Q4 2025 earnings, here are the numbers [charts] Apple reports Q4 2025 earnings, here are the numbers [charts]](https://i0.wp.com/9to5mac.com/wp-content/uploads/sites/6/2024/12/apple-logo-store.jpg?resize=1200%2C628&quality=82&strip=all&ssl=1)